tiprankstipranks
Trending News
More News >
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market

Boundless Bio Inc. (BOLD) Income Statement

Compare
36 Followers

Boundless Bio Inc. Income Statement

Last quarter (Q3 2025), Boundless Bio Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Boundless Bio Inc.'s net income was $-13.88M. See Boundless Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.09M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 72.18M$ 54.80M$ 46.47M$ 25.30M$ 134.37M
Depreciation and Amortization
$ 1.09M$ 957.00K$ 942.00K$ 682.00K$ 7.46M
EBITDA
$ -64.28M$ -53.84M$ -45.53M$ -24.62M$ -121.36M
Operating Income
$ -73.27M$ -54.80M$ -46.47M$ -25.30M$ -134.37M
Other Income/Expenses
$ 7.90M$ 5.36M$ 568.00K$ 91.00K$ 5.55M
Pretax Income
$ -65.36M$ -49.43M$ -45.90M$ -25.21M$ -128.82M
Net Income
$ -65.36M$ -49.43M$ -45.90M$ -25.21M$ -128.82M
Per Share Metrics
Basic EPS
$ -3.85$ -2.22$ -2.06$ -1.13$ -2.93
Diluted EPS
$ -3.85$ -2.22$ -2.06$ -1.13$ -2.93
Weighted Average Shares Outstanding
16.98M 22.24M 22.24M 22.24M 44.03M
Weighted Average Shares Outstanding (Diluted)
16.98M 22.24M 22.24M 22.24M 44.03M
Currency in USD

Boundless Bio Inc. Earnings and Revenue History